The Ink4a Tumor Suppressor Gene Product, p19Arf, Interacts with MDM2 and Neutralizes MDM2's Inhibition of p53

1998 
Abstract The INK4a gene encodes two distinct growth inhibitors—the cyclin-dependent kinase inhibitor p16 Ink4a , which is a component of the Rb pathway, and the tumor suppressor p19 Arf , which has been functionally linked to p53. Here we show that p19 Arf potently suppresses oncogenic transformation in primary cells and that this function is abrogated when p53 is neutralized by viral oncoproteins and dominant-negative mutants but not by the p53 antagonist MDM2. This finding, coupled with the observations that p19 Arf and MDM2 physically interact and that p19 Arf blocks MDM2-induced p53 degradation and transactivational silencing, suggests that p19 Arf functions mechanistically to prevent MDM2's neutralization of p53. Together, our findings ascribe INK4a 's potent tumor suppressor activity to the cooperative actions of its two protein products and their relation to the two central growth control pathways, Rb and p53.
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    68
    References
    1446
    Citations
    NaN
    KQI
    []